Launching the First Non-Invasive Point of Care Diagnostic Test for Traumatic Brain Injury

Project description

A biochemical test for traumatic brain injury diagnosis

Doctors in an emergency room reach diagnosis of a suspected traumatic brain injury (TBI) using a combination of CT and MRI scans as well as a neurological evaluation. The EU-funded Medicortex project has developed an alternative TBI diagnostic method which is fast and easy to use and can be performed at the point of care, offering immediate results. The test is based on TBI-specific biomarkers that can be detected in saliva and urine samples, and it has great potential to improve the clinical outcome of millions of people with TBI worldwide.

Fields of science

• natural sciences › biological sciences › neurobiology
• engineering and technology › medical engineering › diagnostic imaging › computed tomography
• engineering and technology › medical engineering › medical laboratory technology › laboratory samples analysis

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

MEDICORTEX FINLAND OY

Net EU contribution

€ 50 000,00

Address

Itainen Pitkakatu 4b 4
20520 Turku
Finland

Region

Manner-Suomi › Etelä-Suomi › Varsinais-Suomi

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 21 429,00